These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 37475164)

  • 1. Using serum anti-Müllerian hormone levels to predict the chance of live birth after spontaneous or assisted conception: a systematic review and meta-analysis.
    Peigné M; Bernard V; Dijols L; Creux H; Robin G; Hocké C; Grynberg M; Dewailly D; Sonigo C
    Hum Reprod; 2023 Sep; 38(9):1789-1806. PubMed ID: 37475164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low anti-Müllerian hormone level is not a risk factor for early pregnancy loss in IVF/ICSI treatment.
    Peuranpää P; Hautamäki H; Halttunen-Nieminen M; Hydén-Granskog C; Tiitinen A
    Hum Reprod; 2020 Mar; 35(3):504-515. PubMed ID: 32219343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis.
    van Tilborg TC; Oudshoorn SC; Eijkemans MJC; Mochtar MH; van Golde RJT; Hoek A; Kuchenbecker WKH; Fleischer K; de Bruin JP; Groen H; van Wely M; Lambalk CB; Laven JSE; Mol BWJ; Broekmans FJM; Torrance HL;
    Hum Reprod; 2017 Dec; 32(12):2485-2495. PubMed ID: 29121350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the cumulative chance of live birth over multiple complete cycles of in vitro fertilization: an external validation study.
    Leijdekkers JA; Eijkemans MJC; van Tilborg TC; Oudshoorn SC; McLernon DJ; Bhattacharya S; Mol BWJ; Broekmans FJM; Torrance HL;
    Hum Reprod; 2018 Sep; 33(9):1684-1695. PubMed ID: 30085143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delay in IVF treatment up to 180 days does not affect pregnancy outcomes in women with diminished ovarian reserve.
    Romanski PA; Bortoletto P; Rosenwaks Z; Schattman GL
    Hum Reprod; 2020 Jul; 35(7):1630-1636. PubMed ID: 32544225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro fertilization and multiple pregnancies: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(18):1-63. PubMed ID: 23074488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biopsying, fragmentation and autotransplantation of fresh ovarian cortical tissue in infertile women with diminished ovarian reserve.
    Lunding SA; Pors SE; Kristensen SG; Landersoe SK; Jeppesen JV; Flachs EM; Pinborg A; Macklon KT; Pedersen AT; Andersen CY; Andersen AN
    Hum Reprod; 2019 Oct; 34(10):1924-1936. PubMed ID: 31593582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of thyroid autoimmunity in euthyroid women on live birth rate after IUI.
    Unuane D; Velkeniers B; Bravenboer B; Drakopoulos P; Tournaye H; Parra J; De Brucker M
    Hum Reprod; 2017 Apr; 32(4):915-922. PubMed ID: 28333271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cumulative live birth rates in low-prognosis women.
    Leijdekkers JA; Eijkemans MJC; van Tilborg TC; Oudshoorn SC; van Golde RJT; Hoek A; Lambalk CB; de Bruin JP; Fleischer K; Mochtar MH; Kuchenbecker WKH; Laven JSE; Mol BWJ; Torrance HL; Broekmans FJM;
    Hum Reprod; 2019 Jun; 34(6):1030-1041. PubMed ID: 31125412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low ovarian reserve and risk of miscarriage in pregnancies derived from assisted reproductive technology.
    Chinè A; Reschini M; Fornelli G; Basili L; Busnelli A; Viganò P; Muzii L; Somigliana E
    Hum Reprod Open; 2023; 2023(3):hoad026. PubMed ID: 37287447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into ovarian response with a fixed low dose FSH stimulation in an IUI programme: the PRORAILS study.
    Rutten A; van Ballegooijen H; Broekmans F; Cohlen B;
    Hum Reprod; 2022 Jun; 37(7):1440-1450. PubMed ID: 35460412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oocyte matched follicular fluid anti-Müllerian hormone is an excellent predictor of live birth after fresh single embryo transfer.
    Ciepiela P; Dulęba AJ; Kario A; Chełstowski K; Branecka-Woźniak D; Kurzawa R
    Hum Reprod; 2019 Nov; 34(11):2244-2253. PubMed ID: 31725884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-müllerian hormone as a predictor for live birth among women undergoing IVF/ICSI in different age groups: an update of systematic review and meta-analysis.
    Li NJ; Yao QY; Yuan XQ; Huang Y; Li YF
    Arch Gynecol Obstet; 2023 Jul; 308(1):43-61. PubMed ID: 35907969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of intracytoplasmic sperm injection in non-male factor infertility in advanced maternal age.
    Tannus S; Son WY; Gilman A; Younes G; Shavit T; Dahan MH
    Hum Reprod; 2017 Jan; 32(1):119-124. PubMed ID: 27852688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of Anti-Müllerian hormone in low and extremely low ovarian reserve in relation to live birth after in vitro fertilization.
    Reijnders IF; Nelen WL; IntHout J; van Herwaarden AE; Braat DD; Fleischer K
    Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():45-50. PubMed ID: 26967346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of serum Anti-Mullerian Hormone levels on the results of assisted reproductive technologies. Single-center retrospective study from 2011 cycles (ICSI and bilateral tubal obstruction excluded)].
    Dosso N; Robin G; Catteau-Jonard S; Pigny P; Leroy-Billiard M; Dewailly D
    J Gynecol Obstet Biol Reprod (Paris); 2015 Jan; 44(1):63-71. PubMed ID: 24951378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 1: The predicted poor responder.
    van Tilborg TC; Torrance HL; Oudshoorn SC; Eijkemans MJC; Koks CAM; Verhoeve HR; Nap AW; Scheffer GJ; Manger AP; Schoot BC; Sluijmer AV; Verhoeff A; Groen H; Laven JSE; Mol BWJ; Broekmans FJM;
    Hum Reprod; 2017 Dec; 32(12):2496-2505. PubMed ID: 29121326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICSI does not increase the cumulative live birth rate in non-male factor infertility.
    Li Z; Wang AY; Bowman M; Hammarberg K; Farquhar C; Johnson L; Safi N; Sullivan EA
    Hum Reprod; 2018 Jul; 33(7):1322-1330. PubMed ID: 29897449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.